Seeding the Infant Gut in Early Life-Effects of Maternal and Infant Seeding with Probiotics on Strain Transfer, Microbiota, and Gastrointestinal Symptoms in Healthy Breastfed Infants

Nutrients. 2023 Sep 15;15(18):4000. doi: 10.3390/nu15184000.

Abstract

We investigated the effects of two dosing regimens of two multi-strain probiotic products on the gut microbiota of breastfed infants, including the transfer of the dosed strains and clinical outcomes. In forty-seven dyads, infants were either exposed through maternal intake (MS) of Lactobacillus acidophilus LA-5, Bifidobacterium animalis subsp. lactis BB-12, Lacticaseibacillus rhamnosus LGG, and Bifidobacterium longum subsp. infantis Bifin02 from gestational week thirty-three until four weeks after birth (n = 24) or dosed directly (IS) with the same strains except for LA-5 starting within 24 h after birth until day 28 (n = 23). Infant stool samples were collected on day 0, 14, 28, and 42 after birth. Gastrointestinal symptoms were assessed by parents using an electronic diary. Microbiota composition was determined using 16S rRNA sequencing, and strain recovery was analyzed by qPCR. Notably, 100% of the IS infants were colonized with Bifin02 after 14 days as opposed to only 25% of the MS infants. Mean stool frequency was significantly lower in IS infants compared to MS infants and IS infants had softer stools on day 14, 28, and 42. A significantly steeper slope of progression of inconsolable crying and fussing was observed in MS infants compared to IS infants. In conclusion, direct infant seeding induced a faster increase in fecal bifidobacteria abundancy and Bifin02 recovery compared to dosed through the maternal intake.

Keywords: Bifidobacterium animalis subsp. lactis BB-12 (DSM15954) (BB-12®); Bifidobacterium longum subsp. infantis Bifin02 (DSM33361) (ISTILOS™); Lacticaseibacillus rhamnosus LGG (DSM33156) (LGG®); Lactobacillus acidophilus LA-5 (DSM13241) (LA-5®); gastrointestinal symptoms; gut microbiome; infants; probiotics.

MeSH terms

  • Bifidobacterium animalis*
  • Bifidobacterium longum subspecies infantis / genetics
  • Breast Feeding
  • Feces / microbiology
  • Female
  • Humans
  • Infant
  • Lactobacillus acidophilus
  • Microbiota*
  • Probiotics*
  • RNA, Ribosomal, 16S / genetics

Substances

  • RNA, Ribosomal, 16S

Grants and funding

Chr. Hansen A/S: Denmark provided the funding to conduct the clinical study to perform the data analysis.